Structured evidence table for Glutamine Gut Barrier Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Glutamine Gut Barrier Randomized Trial | This review outlines the historical development and mechanistic basis of CeD, examines shortcomings of the GFD, evaluates emerging biomarkers and targeted therapeutics with corresponding trial evidence, and provides a brief critical appraisal of these interventions. | 3 | Mundhra Sandeep K (2026) | Beyond gluten-free diet: Novel therapeutic frontiers in celiac disease armamentarium |
| Glutamine Gut Barrier Randomized Trial | High-quality narrative reviews, systematic reviews, and meta-analyses were also consulted to ensure comprehensive coverage and cross-verification of evidence. | 3 | Mundhra Sandeep K (2026) | Beyond gluten-free diet: Novel therapeutic frontiers in celiac disease armamentarium |
| Glutamine Gut Barrier Randomized Trial | According to a 2024 population-level analysis and burden review, the estimated prevalence in the general population now ranges between 0.7% and 2.9%, with higher rates among at-risk groups (first-degree relatives, patients with autoimmune comorbidities) and a clear female predominance[]. | 3 | Mundhra Sandeep K (2026) | Beyond gluten-free diet: Novel therapeutic frontiers in celiac disease armamentarium |
| Glutamine Gut Barrier Randomized Trial | Celiac disease is managed with a gluten-free diet, which is difficult to sustain and often fails to achieve full mucosal recovery. | 3 | Mundhra Sandeep K (2026) | Beyond gluten-free diet: Novel therapeutic frontiers in celiac disease armamentarium |
| Glutamine Gut Barrier Randomized Trial | 11 12 11 13 14 15 16 17 18 19 Since the beginning of the COVID-19 crisis, public interest in hygiene, immunity, and inflammation has increased. | 3 | Lesgards Jean-François (2026) | Whey Proteins and Immunity: Mechanisms Underlying Immune System Reinforcement and Protection Against Viral and Bacterial Infections |
| Glutamine Gut Barrier Randomized Trial | Dairy intake, particularly low-fat products, has been associated with reduced COVID-19 severity and hospitalization [,]. | 3 | Lesgards Jean-François (2026) | Whey Proteins and Immunity: Mechanisms Underlying Immune System Reinforcement and Protection Against Viral and Bacterial Infections |
| Glutamine Gut Barrier Randomized Trial | More broadly, diets rich in fruits, vegetables, and omega-3s, and low in processed foods, may reduce inflammation and infection risk [,,], whereas malnutrition and obesity impair immunity and increase COVID-19 severity []. | 3 | Lesgards Jean-François (2026) | Whey Proteins and Immunity: Mechanisms Underlying Immune System Reinforcement and Protection Against Viral and Bacterial Infections |
| Glutamine Gut Barrier Randomized Trial | 1 The innate immune system provides rapid, nonspecific defense through barriers, cytokines, and cells such as macrophages, dendritic cells, and NK cells, while the adaptive system generates antigen-specific and long-lasting protection via T and B lymphocytes, forming an integrated network essential for host defense []. | 3 | Lesgards Jean-François (2026) | Whey Proteins and Immunity: Mechanisms Underlying Immune System Reinforcement and Protection Against Viral and Bacterial Infections |
Source documents